In 2019, the United Nations Office on Drugs and Crime and the United Nations Commission on Narcotic Drugs convened to address the global drug problem. Their mission? To strengthen actions at national, regional, and international levels. Fast forward to 2024, and the mid-term review in Vienna featured a remarkable guest: Dr. Jacci Bainbridge, PharmD.
Cannabis Education and Clinical Trials
Dr. Bainbridge, a professor at the University of Colorado Skaggs School of Pharmacy, testified about her extensive work with cannabis. Her expertise extends beyond theory—she actively engages in clinical trials and educates patients. In the Neurology Clinic at the Anschutz Outpatient Pavilion, she treats individuals with neurologic diseases, including epilepsy, Parkinson’s disease, multiple sclerosis, migraines, and Willis-Ekbom disease (formerly known as Restless Legs Syndrome).
Beyond Innocence: Cannabis and Drug Interactions
During her U.N. address, Dr. Bainbridge emphasized the importance of understanding drug interactions, particularly with cannabis. While acknowledging its benefits, she advocates for regulation due to potential harm. Her insights contribute to informed decision-making in the evolving landscape of cannabis use.
A Call for Caution and Progress
As the Commission on Narcotic Drugs reviews international drug policies until 2029, Dr. Bainbridge’s voice resonates. Cannabis, once considered innocuous, now demands thoughtful consideration. Let us move forward with both caution and progress, recognizing its complexities and impact on global health.
